Core Viewpoint - The article discusses ongoing legal actions against Yitong Century (300310) due to false statements leading to investor claims, with a focus on recent court rulings and financial misconduct by the company [1][2]. Group 1: Legal Proceedings - Yitong Century is currently facing investor claims related to false statements, with lawsuits filed and ongoing efforts to accept additional claims from investors [1]. - A civil judgment was issued on December 30, 2025, requiring Yitong Century to compensate 109 investors a total of 2,729,003.27 yuan, with certain individuals held jointly liable for the company's debts [1]. - The law firm representing the investors has noted that previous claims have resulted in settlements, and they continue to pursue further cases [1]. Group 2: Financial Misconduct - An investigation revealed that from May 1 to December 31, 2017, Yitong Century's subsidiary, Beitai Health, engaged in financial fraud, inflating revenue by 97.34 million yuan, costs by 52.61 million yuan, and total profits by 40.84 million yuan, which constituted 3.7%, 9.75%, and 15.67% of the company's reported figures, respectively [2]. - This fraudulent activity led to the issuance of an administrative penalty by the China Securities Regulatory Commission on June 21, 2023, highlighting the company's failure to disclose accurate financial information in its annual reports [2]. Group 3: Investor Eligibility for Claims - Investors who purchased Yitong Century shares between April 3, 2018, and November 4, 2022, and sold or held their shares after November 4, 2022, are still eligible to file claims for compensation [3].
宜通世纪被判决赔偿投资者272万,目前还可起诉